{"pub": "fox", "url": "https://foxbusiness.com/markets/sanofi-recall-zantac-us-canada-cancer-risks", "downloaded_at": "2019-10-19 11:30:01.724753+00:00", "title": "Sanofi recalls Zantac in US, Canada over cancer risks", "language": "en", "text": "Pharmaceutical giant Sanofi announced Friday it will voluntarily recall heartburn drug Zantac in the U.S. and Canada because of concerns over potential cancer risks.\n\nContinue Reading Below\n\nThe French drugmaker said it initiated the recall due to the drug\u2019s possible contamination with an ingredient called N-nitrosodimethylamine (NDMA). Sanofi said it is working with health authorities to determine the \u201clevel and extent of the recall.\u201d\n\n\u201cDue to inconsistencies in preliminary test results of the active ingredient used in the U.S. and Canadian products, Sanofi has made the decision to conduct the voluntary recall in the U.S. and Canada as the investigation continues,\u201d the company said in a statement.", "description": "Sanofi said it is working with health authorities to determine the \u201clevel and extent of the recall.\u201d", "authors": [], "top_image": "https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2019/09/0/0/zantac-iStock.jpg?ve=1&tl=1", "published_at": "2019-10-18"}